Anaplastic Kaposi’s Sarcoma of the Adrenal in an HIV-negative Patient With Literature Review

Kaposi’s Sarcoma (KS) occurs as a pathological entity that may be classified into four different types: classic, endemic, epidemic, and iatrogenic. It can arise among HIV-positive subjects or within immunosuppression, yet exceptionally of tuberculous origin. We describe a new case report of an HIV-negative patient, manifesting Kaposi’s disease in the course of tuberculosis, with the aim to assess this uncommon disorder and to outline this rare atypical association.

Download Full-text

Simultaneous Kaposi's sarcoma and Castleman's disease in a HIV-negative patient. Response to rituximab and doxorubicin

Medicina Clínica ◽

10.1016/j.medcli.2019.09.013 ◽

2020 ◽

Vol 155 (12) ◽

pp. 565-566

Author(s):

Mónica García-Arpa ◽

Carmen Calle-Primo ◽

Francisco Martín-Dávila

Keyword(s):

Kaposi's Sarcoma ◽

Castleman’S Disease ◽

Kaposi’S Sarcoma ◽

Castleman's Disease ◽

Patient Response ◽

Negative Patient ◽

Hiv Negative

Download Full-text

Kaposi’s sarcoma in an HIV-negative patient

Dermatology Online Journal ◽

10.5070/d32212033378 ◽

2016 ◽

Vol 22 (12) ◽

Author(s):

Shields Callahan ◽

Randie H Kim ◽

Nooshin Brinster ◽

Jo-Ann Latkowski

Keyword(s):

Kaposi's Sarcoma ◽

Kaposi’S Sarcoma ◽

Negative Patient ◽

Hiv Negative

Download Full-text

A Case of Kaposi’s Sarcoma in a HIV Negative Patient with CLL Treated with Rituximab

Blood ◽

10.1182/blood.v124.21.4970.4970 ◽

2014 ◽

Vol 124 (21) ◽

pp. 4970-4970

Author(s):

Anuradha Avinash Belur ◽

Arun Kumar Arumugam Raajasekar ◽

Srikant Nannapaneni ◽

Thandavababu Chelliah

Keyword(s):

Kaposi's Sarcoma ◽

Conflicts Of Interest ◽

Kaposi Sarcoma ◽

Kaposi’S Sarcoma ◽

Skin Lesions ◽

Elisa Test ◽

Lymphocytic Leukemia ◽

Cell Mediated Immunity ◽

Negative Patient ◽

Hiv Negative

Abstract Case Description: - A 76 year old lady was diagnosed with Chronic Lymphocytic Leukemia (CLL) with 11 q deletion after she presented with generalized lymphadenopathy and anemia. She was treated with rituximab 375mg/m2 day1 and bendamustine 60mg/m2 on day 1 and day 2 and completed six cycles of treatment. After the sixth cycle she developed multiple itchy, papular lesions with bleeding on both lower extremities. She was evaluated multiple times by vascular surgery and dermatology without a definitive diagnosis. She underwent a biopsy with staining for HHV-8, CD31 and CD34 which was positive confirming the diagnosis of Kaposi sarcoma. ELISA test for HIV was negative. She was started on treatment with Doxorubicin 20 mg/m2every 3 weeks and with 3 cycles there was significant regression of the lesions. Discussion-: We describe a case of CLL which was initially started on treatment with rituximab and bendamustine. She tolerated the treatment well, but a few months later presented with skin lesions which on biopsy was diagnosed as Kaposi sarcoma. It is very uncommon for Kaposi sarcoma to develop in a HIV negative patient. This patient was immunocompromised with recent chemotherapy. Rituximab specifically depletes B cells and leads to impaired T cell mediated immunity. This case illustrates the importance of a high index of suspicion in patients treated with rituximab as it is used for a number of hematologic malignancies like leukemia, lymphoma as well as non-malignant conditions like autoimmune disorders. While infusion reactions and reactivation of hepatitis B are side effects physicians are aware of and cautious of while using rituximab, Kaposi’s Sarcoma remains a less known side effect. Awareness of this possibility is important in physicians prescribing rituximab. Footnotes * Asterisk with author names denotes non-ASH members. Disclosures No relevant conflicts of interest to declare.

Download Full-text